COMMON STOCK PURCHASE WARRANT INTELGENX TECHNOLOGIES CORP.Common Stock Purchase • August 26th, 2013 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, •(the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Original Issue Date (as defined below) (the “Exercisability Date”) and on or prior to the close of business on the date that is thirty (30) months following the Exercisability Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from IntelGenx Technologies Corp., a Delaware corporation (the “Company”), up to _______1 shares (the “Warrant Shares”) of common stock, par value $0.00001 (the “Common Stock”), of the Company.
INTELGENX TECHNOLOGIES CORP. • Units Each Unit Consisting of One Share of Common Stock and • of One Warrant to Purchase One Share of Common Stock PLACEMENT AGENT AGREEMENTPlacement Agent Agreement • August 26th, 2013 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
PLACEMENT AGENT WARRANT INTELGENX TECHNOLOGIES CORP.IntelGenx Technologies Corp. • August 26th, 2013 • Pharmaceutical preparations • New York
THIS PLACEMENT AGENT WARRANT (the “Warrant”), issued pursuant to Section 2(e) of the Placement Agent Agreement (the “Placement Agent Agreement”), dated as of August __, 2013, by and between the Company and Roth Capital Partners, LLC, certifies that, for value received, •(the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Original Issue Date (as defined below) (the “Exercisability Date”) and on or prior to the close of business on the date that is thirty (30) months following the Exercisability Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from IntelGenx Technologies Corp., a Delaware corporation (the “Company”), up to _______1 shares (the “Warrant Shares”) of common stock, par value $0.00001 (the “Common Stock”), of the Company.
IntelGenx Technologies Corp. 6425 Abrams, Ville Saint Laurent Quebec, H4S 1X9 Canada Gentlemen:IntelGenx Technologies Corp. • August 26th, 2013 • Pharmaceutical preparations • New York
The undersigned (the “Investor”) hereby confirms its agreement with IntelGenx Technologies Corp., a Delaware corporation (the “Company”) as follows:
